PMA P930036S001

Device
ACS: CENTAUR AFP IMMUNOASSAY
Applicant
Siemens Healthcare Diagnostics, Inc.
PMA number
P930036
Supplement
S001
Product code
LOK
Decision date
1998-07-15
Classification
Kit, Test, Alpha-fetoprotein For Neural Tube Defects
Generic name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Approval order statement
Approval to add the existing AFP assay performed on the ACS:180 to a new generation of instrumentation, the Centaur and is indicated for the quantitative determination of alpha-fetoprotein (AFP) in the following:human serum and in amniotic fluid from specimens obtained at 15 to 20 weeks gestation, as an aid in detecting open neura tube defects (NTDs) when used in conjucntion with ultrasonography and amniography testing, using the Chiron Diagnostics ACS:Centaur(TM) Automated Chemiluminescence System.

Current openFDA PMA Record#

Device
ACS: CENTAUR AFP IMMUNOASSAY
Applicant
Siemens Healthcare Diagnostics, Inc.
PMA number
P930036
Supplement
S001
Product code
LOK
Generic name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Decision date
1998-07-15
Decision code
APPR
Date received
1998-05-01
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
Approval to add the existing AFP assay performed on the ACS:180 to a new generation of instrumentation, the Centaur and is indicated for the quantitative determination of alpha-fetoprotein (AFP) in the following:human serum and in amniotic fluid from specimens obtained at 15 to 20 weeks gestation, as an aid in detecting open neura tube defects (NTDs) when used in conjucntion with ultrasonography and amniography testing, using the Chiron Diagnostics ACS:Centaur(TM) Automated Chemiluminescence System.